TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Sanofi AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,588,039
|
1,355,611
|
1,067,788 |
| Financial expenses |
4,824
|
158
|
1,325 |
| Earnings before taxes |
72,165
|
38,544
|
51,918 |
| EBITDA |
73,176
|
39,173
|
53,172 |
| Total assets |
859,224
|
787,152
|
526,403 |
| Current assets |
852,740
|
779,523
|
519,491 |
| Current liabilities |
678,434
|
633,684
|
369,893 |
| Equity capital |
160,257
|
133,300
|
137,678 |
| - share capital |
2,712
|
2,664
|
2,488 |
| Employees (average) |
131
|
122
|
144 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.7%
|
16.9%
|
26.2% |
| Turnover per employee |
12,122
|
11,112
|
7,415 |
| Profit as a percentage of turnover |
4.5%
|
2.8%
|
4.9% |
| Return on assets (ROA) |
9.0%
|
4.9%
|
10.1% |
| Current ratio |
125.7%
|
123.0%
|
140.4% |
| Return on equity (ROE) |
45.0%
|
28.9%
|
37.7% |
| Change turnover |
207,986
|
212,056
|
-13,061 |
| Change turnover % |
15%
|
19%
|
-1% |
| Chg. No. of employees |
9
|
-22
|
-10 |
| Chg. No. of employees % |
7%
|
-15%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.